Accendra Health (ACH) is One of The 15 Best NYSE Penny Stocks According to Hedge Funds

Accendra Health Inc. (NYSE:ACH) is one of the 15 best NYSE penny stocks to buy according to hedge funds.

On June 23, Accendra Health Inc. (NYSE:ACH) disclosed the final settlement of its previously disclosed offer, involving its outstanding 4.5% senior notes due 2029 and 6.625% senior notes due 2030. These have been exchanged with fresh 9% senior secured first-lien notes expiring in 2032 and 9.75% senior secured second-lien notes expiring in 2033.

Photo by National Cancer Institute on Unsplash

As part of the Exchange Offers, Accendra issued or anticipates issuing $539.25 million in First Lien Notes, including New Money Notes Issuance. For Second Lien Notes, the amount is projected to be around $698.1 million.

Back on June 17, based on Accendra’s initiation of these latest exchange offerings, S&P Global Ratings confirmed the company’s ‘B’ issuer rating and also changed its outlook from negative to stable. The rating agency also allocated a rating of ‘CCC+’ to the company’s second-lien notes with minimal recovery expectations, and ‘B+’ to its first-lien notes having strong recovery prospects.

The outlook highlights anticipated short-term earnings strain from acquisition and separation costs, along with a loss of a large commercial contract. This is expected to be balanced out by improving credit metrics. The S&P Global Ratings-adjusted leverage is projected to trend towards approximately 5x, while the FOCF-to-debt ratio is expected to exceed 3%.

Accendra Health Inc. (NYSE:ACH) is a provider of healthcare solutions. Its offerings include diabetes medication, in-home care, respiratory treatment, and other patient support services. It also provides equipment for ostomy care, wound care, urology, and incontinence products.

While we acknowledge the risk and potential of ACH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ACH and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.